Cognitive functioning in long-term cancer survivorship: A survey utilizing both standardized neuropsychological and self-report measures

References

• AIRTUM Working Group. (2014). I tumori in Italia - Rapporto 2014 Prevalenza e guarigione da tumori in Italia [Italian cancer figures, report 2014: prevalence and cure of cancer in Italy]. Epidemiologia e Prevenzione, 38. (6 Suppl.1).
   Google Scholar
• Annunziata, M. A., Muzzatti, B., Flaiban, C., Giovannini, L., & Carlucci, M. (2016). Mood states in long-term cancer survivors: An Italian descriptive survey. Supportive Care in Cancer, 24, 3157–3164. doi:10.1007/s00520-016-3134-1
   PubMed Web of Science ®Google Scholar
• Annunziata, M. A., Muzzatti, B., Flaiban, C., Giovannini, L., & Lucchini, G. (2016). Cognitive functioning self-assessment scale (CFSS): Further psychometric data. Applied Neuropsychology: Adult, 1–4. https://doi.org/10.1080/23279095.2016.1225575
   PubMed Web of Science ®Google Scholar
• Annunziata, M. A., Muzzatti, B., Giovannini, L., & Lucchini, G. (2012). Cognitive functioning self-assessment scale (CFSS): Preliminary psychometric data. Psychology, Health & Medicine, 17, 207–212. doi:10.1080/13548506.2011.596552
   PubMed Web of Science ®Google Scholar
• Annunziata, M. A., Muzzatti, B., Mella, S., Narciso, D., Giacalone, A., Fratino, L., & Tirelli, U. (2010). The revised piper fatigue scale (PFS-R) for Italian Cancer patients: A validation study. Tumori, 96(2), 276–281.
   PubMed Web of Science ®Google Scholar
• Argyriou, A. A., Assimakopoulos, K., Iconomou, G., Giannakopoulou, F., & Kalofonos, H. P. (2011). “Chemobrain” or “Chemofog,” the long-term chemotherapy-induced cognitive decline in cancer survivors is real. Journal of Pain & Symptom Management, 41, 126–139. doi:10.1016/j.jpainsymman.2010.04.021
   PubMed Web of Science ®Google Scholar
• Bender, C. M., Sereika, S. M., Berga, S. L., Vogel, V. G., Brufsky, A. M., Paraska, K. K., & Ryan, C. M. (2006). Cognitive impairment associated with adjuvant therapy in breast cancer. Psycho-Oncology, 15, 422–430. doi:10.1002/pon.964
   PubMed Web of Science ®Google Scholar
• Braun, I. M., Rao, S. R., & Pirl, W. F. (2012). Comparison of self-reported cognitive difficulties in a national sample of long-term cancer survivors and cancer-naive controls. Psychosomatics, 53, 68–74. doi:10.1016/j.psym.2011.07.010
   PubMed Web of Science ®Google Scholar
• Burnand, B., Kernan, W. N., & Feinstein, A. R. (1990). Indexes and boundaries for “quantitative significance” in statistical decisions. Journal of Clinical Epidemiology, 43, 1273–1284. doi:10.1016/0895-4356(90)90093-5
   PubMed Web of Science ®Google Scholar
• Colombo, L., Sartori, G., & Brivio, C. (2002). Stima del quoziente intellettivo tramite l’applicazione del TIB (Test Breve di Intelligenza). Giornale Italiano di Psicologia, 3, 613–637. [English Translation: Intelligence quotient estimation by administering the TIB (Test of Intelligence)].
   Google Scholar
• Denlinger, C. S., Ligibel, J. A., Are, M., Scott Baker, K., Demark-Wahnefried, W., Friedman, D. L. … Freedman-Cass, D. A. (2014). Survivorship: Cognitive function, version 1.2014. Journal of the National Comprehensive Cancer Network, 12, 976–986. doi:10.6004/jnccn.2014.0094
   PubMed Web of Science ®Google Scholar
• ESEMeD/MHEDEA. 2000 Investigators (2004). Disability and quality of life impact of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatrica Scandinavica, 109(Suppl. 420), 21–27.
   Google Scholar
• Ganz, P. A., Kwan, L., Castellon, S. A., Oppenhei, A., Bower, J. E., Silverman, D. H., … Belin, T. R. (2013). Cognitive complaints after breast cancer treatments: Examining the relationship with neuropsychological test performance. Journal of the National Cancer Institute, 105, 791–801. doi:10.1093/jnci/djt073
   PubMed Web of Science ®Google Scholar
• Howlader, N., Noone, A. M., Krapcho, M., Garshell, J., Miller, D., Altekruse, S. F., … Cronin, K. A. (eds). (2015). SEER Cancer Statistics Review, 1975–2012. Bethesda, MD: National Cancer Institute.
   Google Scholar
• Inagaki, M., Yoshikawa, E., Matsuoka, Y., Sugawara, Y., Nakano, T., Aechi, T. … the Breast Cancer Survivor’ Brain MRI Database Group. (2007). Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer, 109, 146–156. doi:10.1002/cncr.22368
   PubMed Web of Science ®Google Scholar
• Innamorati, M., Lelli, M., Aiello, S., Di Lorenzo Del Casale, F. L., Russo, S., & Ferrari, V. (2006). Validazione convergente e discriminante della versione italiana della Zung Self-Rating Depression Scale. Psicoterapia Cognitiva e Comportamentale, 12, 343–353. [English Translation: Convergent and discriminant validity of the Italian version of the Zung Self- Rating Depression Scale].
   Google Scholar
• Jung, N. Y., Seo, S. W., Yoo, H., Yang, J. J., Park, S., Kim, Y. J., … Kim H. J. (2016). Classifying anatomical subtypes of subjective memory impairment. Neurobiological of Aging, 48, 53–60. doi:10.1016/j.neurobiolaging.2016.08.010
   PubMed Web of Science ®Google Scholar
• Koch, L., Bertram, H., Eberle, A., Holleczek, B., Waldmann, A., & Zeissig, S. R. (2014). Fear of recurrence in long-term breast cancer survivors-still an issue. Results on prevalence, determinants, and the association with quality of life and depression from the cancer survivorship—a multi-regional population-based study. Psycho-Oncology, 23, 547–554. doi:10.1002/pon.3452
   PubMed Web of Science ®Google Scholar
• Koch, L., Jansen, L., Brenner, H., & Arndt, V. (2013). Fear of recurrence and disease progression in long-term (≥5 years) cancer survivors: A systematic review of quantitative studies. Psycho-Oncology, 22, 1–11. doi:10.1002/pon.3022
   PubMed Web of Science ®Google Scholar
• Koppelmans, V., Breteler, M. M., Boogerd, W., Seynaeve, C., Gundy, C., & Schagen, S. B. (2012). Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. Journal of Clinical Oncology, 30, 1080–1086. doi:10.1200/jco.2011.37.0189
   PubMed Web of Science ®Google Scholar
• Ladavas, E., & Berti, A. (2014). Neuropsicologia. Bologna, Italy: Il Mulino. [English Translation: Neuropsychology].
   Google Scholar
• Mehnert, A., Scherwath, A., Schirmer, L., Schleimer, B., Petersen, C., Schulz-Kindermann, F. … Koch, U. (2007). The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy. Patient Education & Counseling, 66, 108–118.
   PubMed Web of Science ®Google Scholar
• Mondini, S., Mapelli, D., Vestri, A., Argara, G., & Bisiacchi, P. S. (2011). Esame neuropsicologico breve, 2. Una batteria di test per lo screening neuropsicologico. Milano, Italy: Raffaello Cortina. [English Translation: Brief Neuropsychological Exam, 2. A test battery for the neuropsychological screening].
   Google Scholar
• Moore, H. C. (2014). An overview of chemotherapy-related cognitive dysfunction, or “chemobrain.” Oncology (Williston Park), 28, 797–804.
   PubMed Web of Science ®Google Scholar
• Noggle, C. A., & Dean, R. S. (2013). The neuropsychology of cancer and oncology. New York, NY: Springer.
   Google Scholar
• Piper, B. F., Dibble, S. L., Dodd, M. J., Weiss, M. C., Slaughter, R. E., & Paul, S. M. (1998). The revised Piper Fatigue Scale: Psychometric evaluation in women with breast cancer. Oncology Nursing Forum, 25, 677–684.
   PubMedGoogle Scholar
• Quesnel, C., Savard, J., & Ivers, H. (2009). Cognitive impairments associated with breast cancer treatments: Results from a longitudinal study. Breast Cancer Research & Treatment, 116, 113–123. doi:10.1007/s10549-008-0208-x
   PubMed Web of Science ®Google Scholar
• Seigers, R., & Fardell, J. E. (2011). Neurobiological basis of chemotherapy-induced cognitive impairment: A review of rodent research. Neuroscience & Biobehavioral Reviews, 35, 729–741. doi:10.1016/j.neubiorev.2010.09.006
   PubMed Web of Science ®Google Scholar
• Simò, M., Rifà-Ros, X., Rodriguez-Fornells, A., & Bruna, J. (2013). Chemobrain: A systematic review of structural and functional neuroimaging studies. Neuroscience & Biobehavioral Reviews, 37, 1311–1321. doi:10.1016/j.neubiorev.2013.04.015
   PubMed Web of Science ®Google Scholar
• Spielberger, C. D. (1983). State-Trait Anxiety Inventory (Form Y). Palo Alto, CA: Mind Garden.
   Google Scholar
• Spielberger, C. D. (1989). S.T.A.I. (State-Trait-Anxiety Inventory). Inventario per l’ansia di stato e di tratto. Forma Y. Firenze, Italy: Organizzazioni Speciali.
   Google Scholar
• Tannock, I. F., Ahles, T. A., Ganz, P. A., & Van Dam, F. S. (2004). Cognitive impairment associated with chemotherapy for cancer: Report of a workshop. Journal of Clinical Oncology, 22, 2233–2239. doi:10.1200/jco.2004.08.094
   PubMed Web of Science ®Google Scholar
• Vardy, J., Wefel, J. S., Ahles, T., Tannock, I. F., & Schagen, S. B. (2008). Cancer and cancer-therapy related cognitive dysfunction: An international perspective from the Venice cognitive workshop. Annals of Oncology, 19, 623–629. doi:10.1093/annonc/mdm500
   PubMed Web of Science ®Google Scholar
• Wefel, J. S., Saleeba, A. K., Buzdar, A. U., & Meyers, C. A. (2010). Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer, 116, 3348–3356. doi:10.1002/cncr.25098
   PubMed Web of Science ®Google Scholar
• Zheng, Y., Luo, J., Bao, P., Cai, H., Hong, Z., Ding, D. … Dai, Q. (2014). Long-term cognitive function change among breast cancer survivors. Breast Cancer Research & Treatment, 146, 599–609. doi:10.1007/s10549-014-3044-1
   PubMed Web of Science ®Google Scholar
• Zung, W. W. K. (1965). Self-reporting depression scale. Archives of General Psychiatry, 12, 63–70. doi:10.1001/archpsyc.1965.01720310065008
   PubMed Web of Science ®Google Scholar